IRIS
PRETE, MARCELLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.564
AS - Asia 2.640
EU - Europa 2.539
SA - Sud America 656
AF - Africa 97
Continente sconosciuto - Info sul continente non disponibili 6
OC - Oceania 5
Totale 11.507
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.474
SG - Singapore 1.144
IT - Italia 884
CN - Cina 630
BR - Brasile 561
SE - Svezia 410
HK - Hong Kong 392
RU - Federazione Russa 318
DE - Germania 220
VN - Vietnam 191
UA - Ucraina 145
GB - Regno Unito 142
FR - Francia 125
FI - Finlandia 103
IN - India 57
AR - Argentina 43
CA - Canada 39
CI - Costa d'Avorio 39
ID - Indonesia 39
JP - Giappone 38
MX - Messico 35
BD - Bangladesh 32
NL - Olanda 26
PL - Polonia 26
ES - Italia 25
ZA - Sudafrica 22
BE - Belgio 20
AT - Austria 19
TR - Turchia 19
IE - Irlanda 16
CZ - Repubblica Ceca 15
EC - Ecuador 14
IQ - Iraq 14
TW - Taiwan 12
UZ - Uzbekistan 12
CH - Svizzera 11
PK - Pakistan 11
VE - Venezuela 10
LT - Lituania 9
MA - Marocco 9
CL - Cile 7
PY - Paraguay 7
SA - Arabia Saudita 7
CO - Colombia 6
AE - Emirati Arabi Uniti 5
DZ - Algeria 5
EU - Europa 5
KR - Corea 5
AZ - Azerbaigian 4
HR - Croazia 4
MY - Malesia 4
PE - Perù 4
PS - Palestinian Territory 4
SN - Senegal 4
TT - Trinidad e Tobago 4
AO - Angola 3
AU - Australia 3
BB - Barbados 3
IR - Iran 3
SY - Repubblica araba siriana 3
UY - Uruguay 3
AL - Albania 2
BA - Bosnia-Erzegovina 2
BG - Bulgaria 2
DO - Repubblica Dominicana 2
EG - Egitto 2
GA - Gabon 2
HU - Ungheria 2
IL - Israele 2
JM - Giamaica 2
JO - Giordania 2
KE - Kenya 2
KZ - Kazakistan 2
MD - Moldavia 2
MT - Malta 2
NO - Norvegia 2
TH - Thailandia 2
TN - Tunisia 2
BJ - Benin 1
BO - Bolivia 1
BW - Botswana 1
BZ - Belize 1
CD - Congo 1
CR - Costa Rica 1
EE - Estonia 1
FJ - Figi 1
GR - Grecia 1
HN - Honduras 1
IM - Isola di Man 1
KH - Cambogia 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LY - Libia 1
ME - Montenegro 1
MK - Macedonia 1
NG - Nigeria 1
NI - Nicaragua 1
NP - Nepal 1
NZ - Nuova Zelanda 1
OM - Oman 1
Totale 11.500
Salva come PNG Salva come JPEG
Città #
Chandler 595
Singapore 589
Ashburn 576
Fairfield 443
Hong Kong 391
Woodbridge 373
Jacksonville 340
Nyköping 331
Houston 292
Beijing 247
Seattle 224
Bari 216
Ann Arbor 215
Cambridge 203
Wilmington 192
New York 127
Roxbury 104
Lawrence 103
Nanjing 91
Los Angeles 87
Dallas 77
Milan 77
Des Moines 71
Ho Chi Minh City 67
Munich 64
Boardman 55
Princeton 49
Brooklyn 48
São Paulo 47
Inglewood 44
Santa Clara 40
Abidjan 39
Hanoi 39
Buffalo 38
Moscow 38
Marseille 31
Rome 30
London 28
Chicago 27
Jakarta 26
Shenyang 26
Tokyo 25
Pune 24
Rio de Janeiro 23
Warsaw 23
Hebei 21
Nanchang 21
Paris 21
Brussels 20
Palermo 20
San Diego 20
Dearborn 19
Council Bluffs 18
Stockholm 18
Denver 17
Orem 17
Poplar 17
Dong Ket 16
Florence 16
Johannesburg 16
Tianjin 16
Belo Horizonte 15
Guangzhou 15
Nuremberg 15
Mexico City 14
Noicattaro 14
Toronto 14
Bologna 13
Frankfurt am Main 13
Helsinki 13
Washington 13
Falkenstein 12
Jiaxing 12
Montreal 12
Tashkent 12
Turku 12
Vienna 12
Atlanta 11
Brno 11
Chennai 11
Phoenix 11
Porto Alegre 11
Redwood City 11
Brasília 10
Changsha 10
Manchester 10
Ankara 9
Dublin 9
The Dalles 9
Auburn Hills 8
Goiânia 8
Querétaro 8
Wuhan 8
Baghdad 7
Boston 7
Columbus 7
Quito 7
San Francisco 7
San Jose 7
Chang-hua 6
Totale 7.502
Salva come PNG Salva come JPEG
Nome #
L'immunoparesi nel mieloma multiplo 640
Anti-carbamylated protein antibodies and skin involvement in patients with systemic sclerosis: An intriguing association 183
Autoimmune uveitis: clinical, pathogenetic, and therapeutic features 176
CD20-Mimotope Peptides: A Model to Define the Molecular Basis of Epitope Spreading 170
Anti-centromere protein A antibodies in systemic sclerosis: Significance and origin 161
Clinical correlates of human leucocyte antigen (HLA)-G in systemic sclerosis 160
Early echocardiographic detection of left ventricular diastolic dysfunction in patients with systemic lupus erythematosus asymptomatic for cardiovascular disease 160
Evaluation of the influence of social, demographic, environmental, work-related factors and/or lifestyle habits on Raynaud's phenomenon: a case-control study 158
CD20-depleting therapy in autoimmune diseases: from basic research to the clinic 156
Autoimmune uveitis: a retrospective analysis of 104 patients from a tertiary reference center 149
CD20-Mimotope Peptide Active Immunotherapy in Systemic Lupus Erythematosus and a Reappraisal of Vaccination Strategies in Rheumatic Diseases 147
Autoantibodies to intracellular antigens: generation and pathogenetic role 147
Subspecificities of anticentromeric protein A antibodies identify systemic sclerosis patients at higher risk of pulmonary vascular disease 142
Belimumab restores Treg/Th17 balance in patients with refractory systemic lupus erythematosus 140
AB0695 Subspecificities of Anti-Centromeric-Associated Protein a (CENP-A) Antibodies (AB) Can Identified a Subset of Patients at Higher Risk of Developing Pulmonary Hypertension 139
Clinical correlates of a subset of anti-CENP-A antibodies cross-reacting with FOXE3p53-62 in systemic sclerosis 134
Oxidized low density lipoproteins: The bridge between atherosclerosis and autoimmunity. Possible implications in accelerated atherosclerosis and for immune intervention in autoimmune rheumatic disorders. 132
Serum levels of beta-2-microglobulin-free heavy chain of HLA class I antigen in healthy individuals: relationship to their class I allotype 131
Effectiveness and safety of belimumab in patients with active systemic lupus erythematosus: results from a large, nationwide, multicentric study. 128
Targeting angiogenesis in multiple myeloma by the VEGF and HGF blocking DARPin® protein MP0250: a preclinical study 125
Working and safety profiles of JAK/STAT signaling inhibitors. Are these small molecules also smart? 124
Antiphospholipids syndrome complicated by a systemic capillary leak-like syndrome treated with steroids and intravenous immunoglobulins a case report 122
Vasculitides: Proposal for an integrated nomenclature 121
Inhibition of mTOR complex 2 restrains tumor angiogenesis in multiple myeloma 119
Anti Th/To autoantibodies: a predictor markers for interstitial lung disease in undifferentiated connective tissue disease at risk of systemic sclerosis 119
Severe pulmonary hypertension as the initial manifestation of systemic lupus erythematosus: a case report and review of the literature 116
Case series on amyloidosis and organ involvement: a single center experience 115
Rheumatic disorders as paraneoplastic syndromes 114
Early disease and low baseline damage predict response to belimumab in patients with systemic lupus erythematosus 114
Short-Term Variations in Neutrophil-to-Lymphocyte and Urea-to-Creatinine Ratios Anticipate Intensive Care Unit Admission of COVID-19 Patients in the Emergency Department 114
CD20: A target antigen for immunotherapy of autoimmune diseases 113
Human CD4 internal antigen anti-idiotypic monoclonal antibody. Immunochemical and sequence analysis 113
Extra-articular manifestations of rheumatoid arthritis: an update 113
Analisi molecolare di un anticorpo monoclonale (ACMO) anti-idiotipo 'immagine interna' dell'antigene CD4 110
Anti-carbamylated protein antibodies in patients with systemic sclerosis: an intriguing association with skin involvement 108
Biological therapy with monoclonal antibodies: a novel treatment approach to autoimmune disease 106
Guidelines for biomarkers in autoimmune rheumatic diseases - evidence based analysis 100
Increased serum levels of beta2m-free HLA class I heavy chain in multiple myeloma 99
Antibiotics or No Antibiotics, That Is the Question: An Update on Efficient and Effective Use of Antibiotics in Dental Practice 99
Beta2-microglobulin-free HLA class I heavy chain epitope mimicry by monoclonal antibody HC-10-specific peptide 94
Size variants of beta-2-microglobulin-free human leucocyte antigen class I heavy chain make different contributions to its serum increase in multiple myeloma 94
Adult-onset Still's disease with elderly onset: results from a multicentre study 93
SARS-CoV-2 infection complicated by inflammatory syndrome. Could high-dose human immunoglobulin for intravenous use (IVIG) be beneficial? 92
Beta2-m-free heavy chain levels of HLA-class I antigen combined with serum IgM or platelet count provide two reliable staging systems in multiple myeloma 91
B2 microglobulin-free heavy chain (FHC) of HLA class I antigen in patients with Hodgkin’s and non Hodgkin’s lymphomas 91
Sars-cov-2 inflammatory syndrome. Clinical features and rationale for immunological treatment 91
Right Heart Changes Impact on Clinical Phenotype of Amyloid Cardiac Involvement: A Single Centre Study 90
International consensus: What else can we do to improve diagnosis and therapeutic strategies in patients affected by autoimmune rheumatic diseases (rheumatoid arthritis, spondyloarthritides, systemic sclerosis, systemic lupus erythematosus, antiphospholipid syndrome and Sjogren's syndrome)?: The unmet needs and the clinical grey zone in autoimmune disease management 89
Anticorpi monoclonali nell'immunoterapia delle malattie autoimmuni 87
Cardiovascular risk in patients with Takayasu arteritis directly correlates with diastolic dysfunction and inflammatory cell infiltration in the vessel wall: a clinical, ex vivo and in vitro analysis. 83
Staging multiple myeloma patients with active disease using serum levels of beta2m-free HLA class I heavy chain together with IgM or platelet count 82
Clinical response and analysis of regulatory T cells (Tregs) in a cohort of patients with active Systemic Lupus Erythematosus (SLE) on treatment with belimumab. 82
Amicrobial pustulosis or erosive pustular dermatosis of the inguinal folds: broad of the same spectrum? 81
Analisi molecolare di un anticorpo monoclonale (AcMo) anti-idiotipo “immagine interna” dell’antigene CD4 80
An atypical presentation of intestinal neuroendocrine tumor. 80
Identificazione del peptide che mima l'epitopo localizzato sulla catena pesante HLA-I non associata alla beta 2-microglobulina, riconosciuto dall'anticorpo monoclonale HC-10 79
Subclinical atherosclerosis and history of cardiovascular events in Italian patients with rheumatoid arthritis: Results from a cross-sectional, multicenter GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) study 78
Echocardiographic alteration in patients with systemic lupus erythematosus affected by hepatic steatosis: a cross-sectional single center study 78
null 77
Lupus vasculitis: An overview 76
Immune escape of multiple myeloma cells results from low miR29b and the ensuing epigenetic silencing of proteasome genes 75
Vasculiti primarie sistemiche 75
HLA allele prevalence in disease-modifying antirheumatic drugs-responsive enthesitis and/or arthritis not fulfilling ASAS criteria: Comparison with psoriatic and undifferentiated spondyloarthritis 74
The role of recombinant human erythropoietin alpha in the treatment of chronic anemia in multiple myeloma 72
Involvement of FAB subclass-specific determinants in the interaction of human IgG with Streptococcal Protein (PG) 72
Clinical use of erythropoietin 72
Raynaud’s phenomenon: from molecular pathogenesis to therapy 71
Epstein–Barr Virus in Salivary Samples from Systemic Lupus Erythematosus Patients with Oral Lesions 71
An 82-year-old woman with new onset of multiple purple-reddish nodules during treatment with abatacept for rheumatoid arthritis 70
Constrictive pericarditis due to AL amyloidosis: a case report. 70
Membrane-type metalloprotease activity and HLA class I mRNA splicing in generating tFHC variants in multiple myeloma: clinical significance 69
Minimum structural requirement for CD4 mimicry by anti-idiotipic mAb 16D7 69
Beta-2 microglobulin-free HLA-A class I heavy chain (FHC) A3 and/or A30 soluble products contribute only minimally toserum FHC expression 68
Monoclonal antibodies (mAb) in the immunotherapy (IT) of autoimmune disease (AD) 66
Ruolo degli autoanticorpi nelle patologie autoimmuni 66
B2 microglobulin (b2m)-free HLA class I heavy chain as prognostic marker of multiple myeloma 66
Efficacy, Safety, and Predictor of Response to Belimumab in a Large Nationwide Cohort Study of Patients with Active Systemic Lupus Erythematosus. 66
La neutropenia nei pazienti in trattamento: differenziazione dei fattori di crescita 63
Mieloma multiplo e gammapatie monoclonali: quadri clinici, acquisizioni eziopatogenetiche e progressi terapeutici 63
Functional characterization of peptides mimicking the CD20 epitope recognized by Rituximab 60
Two structurally different peptides mimic a CD20 epitope recognized by rituximab 59
Vasculiti primarie sistemiche 59
Endothelial cells in tumor microenvironment: insights and perspectives 58
Dosaggio della catena pesante degli antigeni di Istocompatibilita' in pazienti con mieloma multiplo (MM) 58
Immunoparesisi in multiple myeloma 58
BETA-2 microglobulin (beta2m)-free HLA Class I heavy chain as prognostic marker of multiple myeloma 57
Impact of Antigen Presentation Mechanisms on Immune Response in Autoimmune Hepatitis 57
Beta 2-microglobulin-free heavy chain (FHC) of HLA class I antigen in patients with Hodgkin's and non-Hodgkin's lymphomas 56
Early echocardiographic detection of left ventricular diastolic dysfunction in patients with systemic lupus erythematosus asymptomatic for cardiovascular disease 55
Biomolecular drugs in IBD: news, limits and perspective 54
Generation of linear and cyclic peptides revealed a unique fine specificity of Rituximab and its possible cross-reactivity with an acid sphingomyelinase-like phosphodiesterasem 3B precursor 54
Systemic lupus erythematosus therapy: new possibilities since 50 years 54
The growing role of precision medicine for the treatment of autoimmune diseases; results of a systematic review of literature and Experts' Consensus 53
Adipose failure through adipocyte overload and autoimmunity 52
A COMPREHENSIVE GENOME-WIDE COPY NUMBER ALTERATIONS (CNAS) ANALYSIS OF HOMOGENEOUSLY TREATED, NEWLY DIAGNOSED MULTIPLE MYELOMA (MM) PATIENTS 52
Difficult therapeutic choices in a patient suffering from severe scleroderma and colon adenocarcinoma. 52
Tumor necrosis factor‑α in systemic lupus erythematosus: Structure, function and therapeutic implications (Review) 52
Un esempio di mimotipo per l'iimunoterapia delle patologie autoimmuni 51
Serum levels of beta2-microglobulin-free heavy chain of HLA class I antigen are increased in patients with multiple myeloma. Role of FHC size variant 50
Paradoxical embolism: relationship between foramen ovale pervious and renal infarction. 50
Totale 9.874
Salva come PNG Salva come JPEG
Categoria #
all - tutte 52.901
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 52.901
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021779 0 0 0 0 0 71 182 109 128 134 96 59
2021/2022808 35 83 6 34 28 65 60 45 38 43 143 228
2022/20231.530 193 201 114 140 164 216 33 180 217 11 42 19
2023/2024701 49 107 37 65 51 179 12 48 23 29 25 76
2024/20252.429 90 26 192 71 62 195 265 241 83 151 359 694
2025/20262.816 781 253 347 634 622 179 0 0 0 0 0 0
Totale 11.930